Maha Research Labs . Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.10 M
- Company Age 18 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 19.77%
- Profit Growth 24.77%
- Ebitda 18.27%
- Net Worth 91.72%
- Total Assets 7.55%
About Maha Research Labs .
Maha Research Labs Pvt . Ltd. (MRLPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 November 2006 and has a history of 18 years and three months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mohammed Kureshi and Laikha Khan serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24239MH2006PTC165564
-
Company No.
165564
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Nov 2006
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Maha Research Labs Pvt . Ltd. offer?
Maha Research Labs Pvt . Ltd. offers a wide range of products and services, including Allopathic Cough Syrup, Guaiphenesin Cough Syrup.
Who are the key members and board of directors at Maha Research Labs .?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohammed Kureshi
|
Director | 15-Nov-2006 | Current |
|
Laikha Khan
|
Director | 15-Nov-2006 | Current |
Financial Performance of Maha Research Labs ..
Maha Research Labs Pvt . Ltd., for the financial year ended 2013, experienced significant growth in revenue, with a 19.77% increase. The company also saw a substantial improvement in profitability, with a 24.77% increase in profit. The company's net worth Soared by an impressive increase of 91.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maha Research Labs .?
In 2017, Maha Research Labs . had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Maha Research Labs .?
Maha Research Labs . has a workforce of 31 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maha Research Labs ., offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maha Research Labs .'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
